171 related articles for article (PubMed ID: 1830872)
1. Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis.
de Châtel R; Makó J; Tóth M; Barna I; Lang RE
Int Urol Nephrol; 1991; 23(2):177-83. PubMed ID: 1830872
[TBL] [Abstract][Full Text] [Related]
2. Changes in plasma atrial natriuretic peptide during hemodialysis: mechanism of elevated levels in patients with chronic renal failure.
Takagi T; Nishikawa M; Inada M
Endocr J; 1993 Apr; 40(2):257-61. PubMed ID: 7951512
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic peptide and cyclic 3'5'-guanosine monophosphate as indicators of fluid volume overload in children with chronic renal failure.
Lettgen B; Bald M; Valleé H; Bonzel KE; Rascher W
Pediatr Nephrol; 1992 Jan; 6(1):60-4. PubMed ID: 1311187
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of haemodialysis and haemofiltration on plasma atrial natriuretic peptide.
Raine AE; Bock A; Muller FB; Erne P; Bolli P; Brunner F; Buhler FR
Nephrol Dial Transplant; 1989; 4(3):222-7. PubMed ID: 2524680
[TBL] [Abstract][Full Text] [Related]
5. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
[TBL] [Abstract][Full Text] [Related]
6. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis.
Wilkins MR; Wood JA; Adu D; Lote CJ; Kendall MJ; Michael J
Clin Sci (Lond); 1986 Aug; 71(2):157-60. PubMed ID: 2941209
[TBL] [Abstract][Full Text] [Related]
7. Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure.
Anderson JV; Raine AE; Proudler A; Bloom SR
J Endocrinol; 1986 Aug; 110(2):193-6. PubMed ID: 2943848
[TBL] [Abstract][Full Text] [Related]
8. Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis.
Plum J; Grabensee B
J Intern Med; 1991 Mar; 229(3):209-16. PubMed ID: 1826125
[TBL] [Abstract][Full Text] [Related]
9. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.
Haug C; Metzele A; Steffgen J; Kochs M; Hombach V; Grünert A
Clin Investig; 1994 Jun; 72(6):430-4. PubMed ID: 7950153
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure.
Hasegawa K; Matsushita Y; Inoue T; Morii H; Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1986 Oct; 63(4):819-22. PubMed ID: 2943754
[TBL] [Abstract][Full Text] [Related]
11. Neurohumoral responses to a single haemodialysis in chronic renal patients.
Uusimaa P; Huttunen K; Ruskoaho H; Linnaluoto M; Ikäheimo M
Acta Physiol Scand; 1999 Jan; 165(1):25-31. PubMed ID: 10072093
[TBL] [Abstract][Full Text] [Related]
12. Plasma human brain natriuretic peptide in chronic renal failure.
Akiba T; Tachibana K; Togashi K; Hiroe M; Marumo F
Clin Nephrol; 1995 Nov; 44 Suppl 1():S61-4. PubMed ID: 8608666
[TBL] [Abstract][Full Text] [Related]
13. [Secretion of atrial natriuretic peptide and vasopressin during hemodialysis in patients with chronic renal failure].
Grzeszczak W; Sornek E; Zukowska-Szczechowska E; Mizera W; Klajnowicz J
Pol Arch Med Wewn; 1995 Sep; 94(3):195-207. PubMed ID: 8596756
[TBL] [Abstract][Full Text] [Related]
14. Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure.
Haug C; Metzele A; Steffgen J; Grünert A
Horm Metab Res; 1994 May; 26(5):246-9. PubMed ID: 8076909
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure.
Buckley MG; Sagnella GA; Markandu ND; Singer DR; MacGregor GA
Clin Sci (Lond); 1989 Nov; 77(5):573-9. PubMed ID: 2531055
[TBL] [Abstract][Full Text] [Related]
16. Plasma alpha-human atrial natriuretic peptide and volume status in chronic haemodialysis patients.
Leunissen KM; Menheere PP; Cheriex EC; van den Berg BW; Noordzij TC; van Hooff JP
Nephrol Dial Transplant; 1989; 4(5):382-6. PubMed ID: 2528086
[TBL] [Abstract][Full Text] [Related]
17. Plasma atrial natriuretic peptide in patients with chronic renal failure.
Chen JH; Tsai JH; Lai YH; Hwang SJ
J Formos Med Assoc; 1990 Aug; 89(8):645-50. PubMed ID: 1981224
[TBL] [Abstract][Full Text] [Related]
18. Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients.
Corboy JC; Walker RJ; Simmonds MB; Wilkins GT; Richards AM; Espiner EA
Clin Sci (Lond); 1994 Dec; 87(6):679-84. PubMed ID: 7874859
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma levels of atrial natriuretic peptide in patients with chronic renal failure: effect of noradrenaline infusion.
Jespersen B; Pedersen EB
Nephrol Dial Transplant; 1988; 3(6):762-7. PubMed ID: 2976128
[TBL] [Abstract][Full Text] [Related]
20. Renal and hemodialysis clearances of endogenous natriuretic peptide. A clinical and experimental study.
Deray G; Maistre G; Cacoub P; Barthelemy C; Eurin J; Carayon A; Masson F; Martinez F; Baumelou A; Legrand JC
Nephron; 1990; 54(2):148-53. PubMed ID: 2138254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
